COMMUNIQUÉS West-GlobeNewswire

First Choice Healthcare Solutions Reports Third Quarter 2018 Results and Update on Strategic Initiatives
08/11/2018
MELBOURNE, Fla., Nov. 08, 2018 (GLOBE NEWSWIRE) -- First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) ("First Choice" or the "Company") , a fully integrated, non-physician-owned, publicly traded healthcare delivery [...]
Veritas Confirms Readiness for Human Trials of CTL-X for Pain; Projected to Start Early Next Month
08/11/2018
VANCOUVER, British Columbia, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) ( “ Veritas ” or the “Company”) is pleased to announce that, despite the catastrophic events [...]
Caladrius Biosciences Appoints Cynthia Schwalm to Board of Directors
08/11/2018
Basking Ridge, New Jersey, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences Appoints Cynthia Schwalm to Board of Directors BASKING RIDGE, N.J. (November 8, 2018) – Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“ [...]
Fluidigm Showcases Immuno-Oncology Innovations for Translational and Clinical Research at SITC 2018
08/11/2018
A comprehensive suite of innovative immuno-oncology applications to improve the future of cancer care SOUTH SAN FRANCISCO, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), a leader in mass [...]
Kane Biotech Schedules Third Quarter 2018 Earnings Conference Call and Business Update
08/11/2018
Conference call to take place Thursday, November 15, 2018 at 4:30pm E.T. WINNIPEG, Manitoba, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE, OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) is pleased [...]
Cognition Therapeutics Initiates Patient Dosing in Phase 2 SHINE Study of Elayta™ in Patients with Mild-to-Moderate Alzheimer's Disease
08/11/2018
Pittsburgh, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , a clinical stage neuroscience company focused on synaptic protection and restoration in Alzheimer’s disease and other neurodegenerative [...]
Proteon Therapeutics to Present at the Stifel 2018 Healthcare Conference November 13th
08/11/2018
WALTHAM, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular [...]
T1D Exchange Launches One-Stop Resource for the Type 1 Diabetes Community
08/11/2018
New Website Puts Patients at the Center of Accelerating Innovation and Improving Care BOSTON, Nov. 08, 2018 (GLOBE NEWSWIRE) -- T1D Exchange today announced the launch of a new T1DExchange.org website featuring cutting- [...]
Intensity Therapeutics Highlights INT230-6 Data in Advanced Solid Tumors at Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting
08/11/2018
Intratumoral injections of INT230-6 were well tolerated with no drug-related serious adverse events or dose-limiting toxicity in Phase 1/2 clinical study Preclinical research demonstrates drug dispersion benefit of [...]
Conatus Pharmaceuticals Announces Presentations and Posters at AASLD Annual Meeting
08/11/2018
SAN DIEGO, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) announced today the schedule of upcoming oral presentations and posters addressing clinical and preclinical results with the [...]
Ovid Therapeutics Reports Third Quarter 2018 Financial Results and Highlights Recent Clinical Progress
08/11/2018
OV101 in Angelman syndrome: Plan to meet with U.S. FDA in the fourth quarter of 2018 to review Phase 2 STARS results and discuss next steps for program OV935/TAK-935 in rare developmental and epileptic encephalopathies [...]
Progenics Pharmaceuticals Announces Third Quarter 2018 Financial Results And Business Update
08/11/2018
AZEDRA ® (iobenguane I 131) Approved by U.S. Food and Drug Administration (FDA) AZEDRA U.S. Launch Progressing and AZEDRA Added to the NCCN Guidelines and Four CMS-Recognized Drug Compendia Phase 3 Study of PyL TM for [...]
Kura Oncology Adds Commercial Veteran Mary Szela to Board of Directors
08/11/2018
Ms. Szela brings expertise in global brand development to Kura as company enters first registration-directed trial SAN DIEGO, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage [...]
Specific Billing J-Code Issued for Trogarzo® by Center for Medicare and Medicaid Services
08/11/2018
MONTREAL, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that Trogarzo ® (ibalizumab-uiyk) injection has been assigned a specific J-Code. The new code will [...]
Trogarzo(MD) obtient un code de facturation « J » spécifique du Centre for Medicare and Medicaid Services
08/11/2018
MONTRÉAL, 08 nov. 2018 (GLOBE NEWSWIRE) -- Theratechnologies inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer qu’un code de facturation « J » spécifique a été assigné à Trogarzo MD (ibalizumab-uiyk) injection [...]
Moleculin Announces New Independent Study Expands Potential Use of Its Pancreatic Drug Candidate WP1122
08/11/2018
Documented potential for drug candidate with characteristics like WP1122 to reverse immune suppression HOUSTON, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a [...]
Clinical Results for BeyondSpring’s Lead Asset, Plinabulin for the Prevention of Chemotherapy-Induced Neutropenia, Demonstrated Superior Immune Profile Compared to Neulasta®
08/11/2018
Company to Present Latest Findings at 2018 Society for Immunotherapy of Cancer’s (SITC) Annual Meeting NEW YORK, Nov. 08, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc . (NASDAQ: BYSI), a global biopharmaceutical company [...]
Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results, Sets Fiscal 2019 Cash Dividend Rate, and Provides Fiscal 2019 Guidance
08/11/2018
CINCINNATI, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the fourth quarter and fiscal year ended September 30, 2018. Business Highlights: Completed [...]
Orchard Therapeutics Strengthens Global Commercial Leadership Team with Appointments of Heads of US and EMEA Region Commercial Operations
08/11/2018
Commercial team preparing for potential gene therapy launches BOSTON and LONDON, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Orchard Therapeutics, a leading commercial-stage biotech company dedicated to transforming the lives of [...]

Pages